JOHN LYDON to Disease Progression
This is a "connection" page, showing publications JOHN LYDON has written about Disease Progression.
Connection Strength
0.233
-
A new isoform of steroid receptor coactivator-1 is crucial for pathogenic progression of endometriosis. Nat Med. 2012 Jul; 18(7):1102-11.
Score: 0.064
-
Hormone dependence in premalignant mammary progression. Cancer Res. 2003 Mar 01; 63(5):1067-72.
Score: 0.034
-
Progesterone's role in mammary gland development and tumorigenesis as disclosed by experimental mouse genetics. Breast Cancer Res. 2002; 4(5):191-6.
Score: 0.032
-
Vaginal Squamous Cell Carcinoma Develops in Mice with Conditional Arid1a Loss and Gain of Oncogenic Kras Driven by Progesterone Receptor Cre. Am J Pathol. 2021 07; 191(7):1281-1291.
Score: 0.030
-
Conditional abrogation of transforming growth factor-? receptor 1 in PTEN-inactivated endometrium promotes endometrial cancer progression in mice. J Pathol. 2017 09; 243(1):89-99.
Score: 0.023
-
a-Galactosidase A knockout mice: progressive organ pathology resembles the type 2 later-onset phenotype of Fabry disease. Am J Pathol. 2015 Mar; 185(3):651-65.
Score: 0.019
-
Alterations in Wnt-?-catenin and Pten signalling play distinct roles in endometrial cancer initiation and progression. J Pathol. 2013 May; 230(1):48-58.
Score: 0.017
-
The synergistic effect of Mig-6 and Pten ablation on endometrial cancer development and progression. Oncogene. 2010 Jul 01; 29(26):3770-80.
Score: 0.014